Diets
ketogenic diet decreases hepatic steatosis liver fat in MASLD/NAFLD
In plain terms: Does the ketogenic diet reduce liver fat in fatty-liver disease (MASLD/NAFLD)?
Part of: 🥗 ketogenic diet
Yes in the short term — very-low-energy keto reduces hepatic steatosis, though this tracks closely with the weight loss it causes rather than being uniquely ketogenic.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (15)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Luukkonen 2020 · Proc Natl Acad Sci U S A | observational | supports | moderate | Human isotope study showed a ketogenic diet rapidly reduced intrahepatic triglyceride via increased hepatic fat oxidation. |
| Schiavo 2022 · Obes Surg | RCT | tested-null | low | Low-calorie ketogenic diet improved lipids, CRP and blood pressure via weight loss in obese OSAS patients, implicating calorie/weight loss rather than ketosis per se as the driver. |
| Cunha 2020 · Front Endocrinol | RCT | supports | low | 2-month very-low-calorie ketogenic diet reduced visceral and liver fat more than a standard low-calorie diet in patients with obesity. |
| Saslow LR et al 2025 · JMIR Formative Research | observational | mixed | low | Pre-post pilot (no comparator arm), n=11 enrolled / 9 completed with liver-fat data, very-low-carbohydrate diet in PNPLA3 (rs738409) risk-genotype MASLD adults over 4 months; hepatic liver fat percent change -33.2% overall (95% CI -86.5 to |
| Haghighatdoost 2016 · Clin Nutr | meta-analysis | supports | low | Meta-analysis found low-carb diets improved some liver measures but intrahepatic-lipid effects were inconsistent across trials. |
| Qadri 2026 · J Hepatol | RCT | mixed | high | RCT found ketogenic and non-ketogenic weight-loss diets reduced intrahepatic triglycerides similarly, indicating benefit is weight-loss-driven not ketosis-specific. |
| Zou 2025 · BMC Gastroenterol | meta-analysis | tested-null | low | Network meta-analysis of MAFLD diets found Mediterranean/IF/DASH improve liver function without keto ranking as uniquely superior. |
| Mardinoglu 2018 · Cell Metab | n-of-1 | supports | moderate | Isocaloric low-carbohydrate diet produced rapid liver-fat reduction with decreased de novo lipogenesis in obese NAFLD subjects. |
| Wang H et al 2024 · Obesity Reviews | observational | mixed | moderate | Network meta-analysis of 174 RCTs (n=10,183) comparing diet, exercise, and pharmacological interventions for NAFLD using endpoints including MRI-PDFF-based steatosis score; GLP-1 receptor agonists ranked best for liver-fat/steatosis improve |
| Farrell 2026 · J Hepatol Rep | RCT | supports | moderate | Randomized pilot in overweight/obese MASLD patients: very-low-energy ketogenic diet produced superior hepatic steatosis reduction vs Mediterranean diet. |
| You Y et al 2025 · study_type: animal | animal | supports | moderate | 2-wk KD in HFD-induced MASLD mice: reduced hepatic fat, ALT/AST; improved mitochondrial dynamics (Fis1/Drp1 down, ATP up) vs HFD control |
| Garbow 2011 · Am J Physiol Gastrointest Liver Physiol | animal | contradicts | low | Long-term ketogenic diet in mice caused hepatic steatosis, ER stress and injury. |
| Sun K et al 2025 · study_type: observational | observational | supports | low | Narrative review: short-to-medium term KD ameliorates hepatic steatosis/steatohepatitis/fibrosis; more effective than calorie-matched high-carb low-fat diets short-term |
| Jornayvaz 2010 · Am J Physiol Endocrinol Metab | animal | contradicts | low | Ketogenic diet in mice caused hepatic insulin resistance from increased hepatic diacylglycerol despite preventing weight gain. |
| Houttu 2021 · Front Nutr | meta-analysis | tested-null | low | Meta-analysis of dietary interventions found macronutrient interventions reduce liver fat, largely mediated by weight loss. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.